Zobrazeno 1 - 10
of 144
pro vyhledávání: '"R, Sostegni"'
Autor:
Alessandro Lavagna, Andrea Cassinotti, Gianmichele Meucci, F. Mocciaro, C. Morselli, Daniela Scimeca, R. Sostegni, Mario Cottone, E. Angelucci, Ambrogio Orlando, R. Cosintino, Livia Biancone, Alessandra Geremia, Fernando Rizzello, Anna Kohn, Antonio Rispo, Fabrizio Bossa, Gabriele Riegler, L. Benazzato, Claudio Papi, Fabiana Castiglione, Enrico Colombo, Angelo Viscido
Publikováno v:
Digestive and Liver Disease. 37:577-583
Background. Almost 20% of patients with active Crohn's disease are refractory to conventional therapy. Infliximab is a treatment of proven efficacy in this group of patients and it is not clear which variables predict a good response. Aims. To evalua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2355a35031104faa43e4f5d05bad9c93
https://doi.org/10.1016/j.dld.2005.01.019
https://doi.org/10.1016/j.dld.2005.01.019
Autor:
Roberto Canaparo, Franco Castagno, Alessandro Lavagna, Sergio D'Antico, Rodolfo Rocca, Elena Ercole, A. Vernetto, L. Crocellà, Marco Daperno, Loredana Serpe, G. P. Zara, C. Rigazio, R. Sostegni, Angelo Pera
Publikováno v:
Alimentary Pharmacology & Therapeutics. 30:843-853
Aliment Pharmacol Ther 30, 843–853 Summary Background Thiopurines are increasingly used in the treatment of inflammatory bowel disease (IBD), being the most common immunosuppressive therapy; however, potentially harmful interactions between thiopur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d346b80fdcf550313464639af40ef5d0
https://doi.org/10.1111/j.1365-2036.2009.04106.x
https://doi.org/10.1111/j.1365-2036.2009.04106.x
Autor:
Angelo Viscido, M. Marrollo, Cosimo Prantera, Vito Annese, Marco Daperno, Alessandro Armuzzi, Gabriele Riegler, R. Sostegni, Anna Kohn, Antonio Gasbarrini, Gianmichele Meucci, Ambrogio Orlando, Livia Biancone, S. Peralta, Maria Cappello
Publikováno v:
Alimentary Pharmacology & Therapeutics. 26:747-756
Background Severe ulcerative colitis is a life-threatening disorder, despite i.v. glucocorticoids treatment. Infliximab has been proposed as a safe rescue therapy. Aim To evaluate short- and long-term effectiveness and safety of infliximab in severe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1eacc5269f8e643954efefd28739bd80
https://doi.org/10.1111/j.1365-2036.2007.03415.x
https://doi.org/10.1111/j.1365-2036.2007.03415.x
Autor:
Francesco Pallone, Emma Calabrese, R. Sostegni, Livia Biancone, Claudio Papi, Fabiana Castiglione, Enrico Colombo, E. Angelucci, Fernando Rizzello, Gianmichele Meucci, Anna Kohn, Carmelina Petruzziello, Mario Cottone, Alessandra Geremia, Ambrogio Orlando, Gabriele Riegler, L. Benazzato, F. Mocciaro
Publikováno v:
Gut. 55:228-233
BACKGROUND AND AIMS: The widespread use of anti-tumour necrosis factor alpha antibody (Infliximab) in Crohn's disease (CD) raises concerns about a possible cancer risk in the long term. In a matched pair study, we assessed whether Infliximab is assoc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8650521e58451e0ba7e0ea126dd12cd0
https://doi.org/10.1136/gut.2005.075937
https://doi.org/10.1136/gut.2005.075937
Autor:
Elena Ercole, Rodolfo Rocca, C. Rigazio, R. Sostegni, N. Scaglione, Angelo Pera, Marco Daperno, F. Castellino
Publikováno v:
Alimentary Pharmacology & Therapeutics. 16:7-12
Approximately 15% of patients with ulcerative colitis have a severe attack requiring hospitalization at some time during their illness. This treatment leads to a remission in 60-80% of patients and non-responders may require a total colectomy. Mortal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::57f06690c6a2d885240c7952e2393c15
https://doi.org/10.1046/j.1365-2036.16.s4.2.x
https://doi.org/10.1046/j.1365-2036.16.s4.2.x
Autor:
R. Sostegni, Marco Daperno, Marco Astegiano, G.C. Molinaro, F. Castellino, Giuseppe Rocca, G. Masoero, C. Rigazio, C. Zaffino, Elena Ercole, Francesca Bresso, Rodolfo Rocca, Angelo Pera
Publikováno v:
Digestive and Liver Disease. 33:755-761
In the past few years, serologic markers have been proposed in inflammatory bowel disease. Anti-Saccharomyces cerevisiae antibodies showed high specificity for Crohn's disease. A prognostic role for serology has also been hypothesised.To evaluate ant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8742383719cd47f7383a98651b9eeab9
https://doi.org/10.1016/s1590-8658(01)80692-7
https://doi.org/10.1016/s1590-8658(01)80692-7
Autor:
R. Sostegni, Luigi Beretta, Marco Astegiano, P. Cesari, Maurizio Vecchi, de Franchis R, Dizioli P, Alberto Prada, Gianmichele Meucci, L. Ferraris, Panelli Mr
Publikováno v:
American Journal of Gastroenterology. 95:469-473
Objective The aim of this study was to evaluate the clinical features and the long term evolution of patients with a well defined initial diagnosis of ulcerative proctitis. Methods Patients with an original diagnosis of ulcerative proctitis who had b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1fbabec4b6486e0e40866de90f691e0d
https://doi.org/10.1111/j.1572-0241.2000.t01-1-01770.x
https://doi.org/10.1111/j.1572-0241.2000.t01-1-01770.x
Autor:
Giuseppe S. Sica, Vito Annese, Carmelina Petruzziello, A. Casà, G. Del Vecchio Blanco, Francesco Pallone, A. Orlando, Emma Calabrese, R. Sostegni, Massimo Campieri, Paolo Gionchetti, Claudio Papi, Renata D'Incà, Livia Biancone
Background. Topical beclomethasone diproprionate has shown efficacy in ulcerative colitis. Aim. To assess, in a multicenter, randomized, double-blind study, the tolerability and safety of topical beclomethasone diproprionate (3 mg) enema and foam ver
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83ae89f6dc1fc65c8a0b664af8709900
http://hdl.handle.net/11585/49696
http://hdl.handle.net/11585/49696
Autor:
R. Monterubbianesi, A. Aratari, A. Armuzzi, M. Daperno, L. Biancone, M. Cappello, V. Annese, G. Riegler, A. Orlando, A. Viscido, G.M. Meucci, A. Gasbarrini, L. Guidi, A. Lavagna, R. Sostegni, S. Onali, C. Papi, A. Kohn
Publikováno v:
Journal of Crohn's and Colitis. 8:S251-S252
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f88df45f17e977e1942d1f0f8166211
https://doi.org/10.1016/s1873-9946(14)60565-1
https://doi.org/10.1016/s1873-9946(14)60565-1
Autor:
D. Rognone, C. Rigazio, Angelo Pera, R. Sostegni, Marco Daperno, Elena Ercole, L. Crocellà, Alessandro Lavagna, Rodolfo Rocca
Publikováno v:
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 40
Endoscopic evaluation of mucosal appearance is important for the clinical management of ulcerative colitis patients, as it offers valuable prognostic tools and data useful to change the management and treatment strategies. In the field of severe ulce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c0c44b64c2f88c492cf5da4d7ff48c7
https://pubmed.ncbi.nlm.nih.gov/18598992
https://pubmed.ncbi.nlm.nih.gov/18598992